Influence of the Prebiotic Effect of Orange Juice on the Bioavailability of Flavanones After Chronic Intake of Orange Juice.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- Determination of acetic acid
研究概览
简要总结
This study aimed investigate the chronic effect of orange juice consumption on gut microbiota and in the bioavailability of flavanones and metabolites by feces, blood and urine analysis.
详细描述
Non-randomized study with interrupted time series and open-label, in which women were enrolled and advised to not consumed foods containing prebiotic, probiotic and fibers, and citrus fruits and beverages during 30 days before of intervention (n=10; BMI 23.8 kg/m2; 28 years). After 30 days, the participants will consume during 60 days 300 mL of orange juice daily. After 60 days of orange juice intervention, the participants will be submitted to 30 days of washout. Samples of blood, urine and feces will collect in five different occasions (baseline, 30 day, 60 day, 90 day, and 120 day) in order to evaluate the prebiotic effect of orange juice on gut microbiota and in the bioavailability of its flavanones. The recruitment process began in September 2016 and the intervention was carried out from October 2016 to February 2017, and the data analysis will start in February 2017. The sample number took into account variances on blood hesperitin levels with a type I error α = 0.05 and a type II error β = 0.2 (80% power) (Silveira et al., 2015). The minimum sample size should have six individuals into the same group. Considering an approximately 15% dropout rate, the final sample size of study was constituted by 10 women. Primary endpoint is the changes in total bacteria population (Lactobacillus spp., Bifidobacterium spp., and reduction of Clostridium spp.) that can result in increased of butyric, acetic, and propionic acid concentrations, and reduction of ammonium production. Secondary endpoint is enhancement of bioavailability of flavanones (hesperitin, naringenin) and metabolites in the blood, urine and feces. Kolmogorov Smirnov and Levene test will be used to assess the normality and homogeneity of data, respectively. One-way analysis of variance (ANOVA) will be apply to determine the intervention effect over the time 0, 30 day, 60 day, 90 day, and 120 day). P significance was set up ≤ 0.05.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 55 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Healthy women BMI 18.5 - 29.9 kg/m2.
排除标准
- •Gastrointestinal diseases Pregnant women Regular use of medications Dietary restrictions, vegetarian diet, macrobiotic, etc. Use of vitamins or dietary supplements Use of probiotics or prebiotics in the last 3 months and antibiotics in the last 6 months.
结局指标
主要结局
Determination of acetic acid
时间窗: 4 months
Ammonium concentration
时间窗: 4 mounths
Total counting of aerobic bacteria and facultative anaerobic bacteria
时间窗: 4 months
Determination of butyric acid
时间窗: 4 months
次要结局
- Insulin curve(4 mounths)
- Low density lipoprotein cholesterol(4 mounths)
- Insulin(4 mounths)
- Total cholesterol(4 mounths)
- Body lean mass(4 months)
- Body fat mass(4 months)
- % body fat(4 months)
- Ratio waist/hip(4 mounths)
- Glucose(4 mounths)
- Bioavailability of hesperitin and naringenin in the blood, urine and feces(4 months)
- Body mass index(4 months)
- High density lipoprotein cholesterol(4 mounths)
- Triglycerides(4 mounths)
- hsCRP(4 mounths)
- Alkaline phosphatase(4 mounths)
- Aspartate enzyme aminotransferase(4 mounths)
- Alanine enzyme aminotransferase(4 mounths)
- GammaGT(4 mounths)
- Glycemic curve(4 mounths)
研究者
Thais Cesar
PhD
São Paulo State University
